Updated guidelines from the Osteoarthritis Research Society International and the UK's National Institute for Health and Care Excellence provide a clear summary of the evidence supporting current therapeutic strategies in osteoarthritis (OA), but in reality they serve to highlight the inability of modern medicine to fully relieve OA pain and dysfunction.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Diagnosis of early stage knee osteoarthritis based on early clinical course: data from the CHECK cohort
Arthritis Research & Therapy Open Access 19 August 2021
-
Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy
Nano-Micro Letters Open Access 23 June 2021
-
Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy
Cell Death & Disease Open Access 25 June 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hochberg, M. C. et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 64, 465–474 (2012).
American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd ed. [online], (2014).
McAlindon, T. E. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 22, 363–388 (2014).
National Institute for Health and Care Excellence (UK). Osteoarthritis: care and management in adults (CG177) [online], (2014).
Zhang, W., Robertson, J., Jones, A. C., Dieppe, P. A. & Doherty, M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann. Rheum. Dis. 67, 1716–1723 (2008).
Sawitzke, A. D. et al. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann. Rheum. Dis. 69, 1459–1464 (2010).
Block, J. A. & Shakoor, N. Lower limb osteoarthritis: biomechanical alterations and implications for therapy. Curr. Opin. Rheumatol. 22, 544–550 (2010).
Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26–35, (2008).
Weinstein, A. M. et al. Estimating the burden of total knee replacement in the United States. J. Bone Joint Surg. Am. 95, 385–392 (2013).
Bedson, J. & Croft, P. R. The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature. BMC Musculoskelet. Disord. 9, 116 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.A.B. is Associate Editor of Osteoarthritis & Cartilage, which is owned by OARSI, and Chair of the ACR Committee on Education.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Block, J. OA guidelines: improving care or merely codifying practice?. Nat Rev Rheumatol 10, 324–326 (2014). https://doi.org/10.1038/nrrheum.2014.61
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.61
This article is cited by
-
Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review
BioDrugs (2021)
-
Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy
Nano-Micro Letters (2021)
-
Diagnosis of early stage knee osteoarthritis based on early clinical course: data from the CHECK cohort
Arthritis Research & Therapy (2021)
-
Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy
Cell Death & Disease (2020)
